RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Merck & Company Incorporated

A collection of news and information related to Merck & Company Incorporated published by this site and its partners.

Top Merck & Company Incorporated Articles see all

Displaying items 1-5
  • Who gains from those drug discount deals? (Spoiler: Drug companies)

    The pharmaceutical industry has been bragging for nearly a decade now about its efforts to help cash-strapped patients pay for expensive prescription drugs. 
  • MetLife, Developer To Build $110 Million Industrial Distribution Center Near Atlanta

    MetLife Inc. announced Thursday it is teaming with a California developer to build a $110 million industrial distribution center near Hartsfield-Jackson Atlanta International Airport in Georgia. The New York life insurer, which has operations in...

    Here's To Hartford's Modern Marvels

    Here's To Hartford's Modern Marvels
    Like many mid-sized cities, Hartford often seems to have an inferiority complex. But one thing the city does not need to feel inferior about is its collection of late 20th- and early 21st-century buildings designed by some of the nation's leading Modern...

    Melanoma drug described as breakthrough gets FDA nod

    The Food and Drug Administration on Thursday gave its speedy approval to a treatment for melanoma that was found to shrink tumors by more than 30% in more than a third of patients with advanced cases of the deadly skin cancer. The FDA designated the...

    Exclusive: U.S. approval of Merck cancer immunotherapy expected soon

    Exclusive: U.S. approval of Merck cancer immunotherapy expected soon
    U.S. regulators are likely to approve Merck & Co's highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline, according to three sources familiar with the situation. If approved by the...